| Dabigatran versus warfarin in patients with atrial fibrillation SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ... New England journal of medicine 361 (12), 1139-1151, 2009 | 14523 | 2009 |
| Apixaban in patients with atrial fibrillation SJ Connolly, J Eikelboom, C Joyner, HC Diener, R Hart, S Golitsyn, ... New England Journal of Medicine 364 (9), 806-817, 2011 | 3414 | 2011 |
| Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial SS Jolly, S Yusuf, J Cairns, K Niemelä, D Xavier, P Widimsky, A Budaj, ... The Lancet 377 (9775), 1409-1420, 2011 | 2524 | 2011 |
| Canadian atrial fibrillation anticoaguiation (CAFA) study SJ Connolly, A Laupacis, M Gent, RS Roberts, JA Cairns, C Joyner Journal of the American College of Cardiology 18 (2), 349-355, 1991 | 1539 | 1991 |
| Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. S Yusuf, SR Mehta, S Chrolavicius, J Pogue, CB Granger, A Budaj, ... JAMA: Journal of the American Medical Association 295 (13), 2006 | 1199 | 2006 |
| Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes … SR Mehta, JF Tanguay, JW Eikelboom, SS Jolly, CD Joyner, CB Granger, ... The Lancet 376 (9748), 1233-1243, 2010 | 1132 | 2010 |
| Dose comparisons of clopidogrel and aspirin in acute coronary syndromes Current–Oasis 7 Investigators New England Journal of Medicine 363 (10), 930-942, 2010 | 1031 | 2010 |
| Rivaroxaban for stroke prevention after embolic stroke of undetermined source RG Hart, M Sharma, H Mundl, SE Kasner, SI Bangdiwala, SD Berkowitz, ... New England Journal of Medicine 378 (23), 2191-2201, 2018 | 986 | 2018 |
| Dronedarone in high-risk permanent atrial fibrillation SJ Connolly, AJ Camm, JL Halperin, C Joyner, M Alings, J Amerena, ... New England Journal of Medicine 365 (24), 2268-2276, 2011 | 826 | 2011 |
| Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse M Kido, L Du, CC Sullivan, X Li, R Deutsch, SW Jamieson, ... Journal of the American College of Cardiology 46 (11), 2116-2124, 2005 | 424 | 2005 |
| Differences in the management and prognosis of women and men who suffer from acute coronary syndromes SS Anand, CC Xie, S Mehta, MG Franzosi, C Joyner, S Chrolavicius, ... Journal of the American College of Cardiology 46 (10), 1845-1851, 2005 | 358 | 2005 |
| Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes A Budaj, JW Eikelboom, SR Mehta, R Afzal, S Chrolavicius, JP Bassand, ... European heart journal 30 (6), 655-661, 2009 | 258 | 2009 |
| Patient prosthesis mismatch is rare after aortic valve replacement: valve size may be irrelevant N Hanayama, GT Christakis, HR Mallidi, CD Joyner, SE Fremes, ... The Annals of thoracic surgery 73 (6), 1822-1829, 2002 | 252 | 2002 |
| Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K … JW Eikelboom, M O'Donnell, S Yusuf, R Diaz, G Flaker, R Hart, ... American heart journal 159 (3), 348-353. e1, 2010 | 238 | 2010 |
| Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial HC Diener, J Eikelboom, SJ Connolly, CD Joyner, RG Hart, GYH Lip, ... The Lancet Neurology 11 (3), 225-231, 2012 | 235 | 2012 |
| Low-Dose vs Standard-Dose Unfractionated Heparin for Percutaneous Coronary Intervention in Acute Coronary Syndromes Treated With Fondaparinux. PG Steg, SS Jolly, SR Mehta, R Afzal, D Xavier, HJ Rupprecht, ... JAMA: Journal of the American Medical Association 304 (12), 2010 | 192 | 2010 |
| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 186 | 2018 |
| Are stentless valves hemodynamically superior to stented valves? A prospective randomized trial G Cohen, GT Christakis, CD Joyner, CD Morgan, M Tamariz, ... The Annals of thoracic surgery 73 (3), 767-778, 2002 | 162 | 2002 |
| Left ventricular mass regression early after aortic valve replacement GT Christakis, CD Joyner, CD Morgan, SE Fremes, KJ Buth, JY Sever, ... The Annals of thoracic surgery 62 (4), 1084-1089, 1996 | 149 | 1996 |
| The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial RJG Peters, C Joyner, JP Bassand, R Afzal, S Chrolavicius, SR Mehta, ... European heart journal 29 (3), 324-331, 2008 | 137 | 2008 |